Table 2.
Clinicopathologic characteristics of patients with stage II–III gastric cancer by the presence of intra-abdominal complications
| Complication group (n = 38) | Non-complication group (n = 227) | P value | ||
| Gender | 0.014 | |||
| Male | 30 | 132 | ||
| Female | 8 | 95 | ||
| Age (years) | 71.2 + 11.5 | 65.9 + 12 | 0.011 | |
| Tumor size (cm) | 7.6 + 4.2 | 6.5 + 3.5 | 0.18 | |
| Tumor location | 0.52 | |||
| Upper | 14 | 64 | ||
| Middle | 11 | 82 | ||
| Lower | 13 | 81 | ||
| Tumor depth | 0.7 | |||
| T1 | 3 | 10 | ||
| T2 | 6 | 43 | ||
| T3 | 12 | 61 | ||
| T4 | 17 | 113 | ||
| Histology | 0.74 | |||
| Differentiated | 16 | 89 | ||
| Undifferentiated | 22 | 138 | ||
| Lymph node metastasis | 0.2 | |||
| N0 | 5 | 47 | ||
| N1 | 9 | 79 | ||
| N2 | 10 | 40 | ||
| N3 | 14 | 61 | ||
| Pathological stage | 0.67 | |||
| II | 15 | 98 | ||
| III | 23 | 129 | ||
| Gastrectomy | 0.25 | |||
| Distal | 13 | 109 | ||
| Proximal | 1 | 8 | ||
| Total | 24 | 110 | ||
| Splenectomy | 0.36 | |||
| Performed | 10 | 45 | ||
| Not performed | 28 | 182 | ||
| Adjuvant chemotherapy | 0.89 | |||
| Performed | 10 | 62 | ||
| Not performed | 28 | 165 | ||
N0, no regional lymph node metastases; N1, metastasis in 1–2 regional lymph nodes; N2, metastasis in 3–6 regional lymph nodes; N3, metastasis in 7 or more regional lymph nodes; T1, tumor has invaded lamina propria or submucosa; T2, tumor has invaded the muscularis propria; T3, tumor has invaded the subserosa; T4, tumor invasion is contiguous to or exposed beyond the serosa or tumor invades adjacent structures.